Tiarnan D L Keenan1, Usha Chakravarthy2, Anat Loewenstein3, Emily Y Chew4, Ursula Schmidt-Erfurth5. 1. Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: tiarnan.keenan@nih.gov. 2. Centre for Experimental Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast, United Kingdom. 3. Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 4. Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA. 5. Department of Ophthalmology and Optometry, Christian Doppler Laboratory for Ophthalmic Image Analyses (OPTIMA), Medical University of Vienna, Vienna, Austria.
Abstract
PURPOSE: To evaluate retinal fluid volume data extracted from optical coherence tomography (OCT) scans by artificial intelligence algorithms in the treatment of neovascular age-related macular degeneration (NV-AMD). DESIGN: Perspective. METHODS: A review was performed of retinal image repository datasets from diverse clinical settings. SETTINGS: Clinical trial (HARBOR) and trial follow-on (Age-Related Eye Disease Study 2 10-year Follow-On); real-world (Belfast and Tel-Aviv tertiary centers). PATIENTS: 24,362 scans of 1,095 eyes (HARBOR); 4,673 of 880 (Belfast); 1,470 of 132 (Tel-Aviv); 511 of 511 (Age-Related Eye Disease Study 2 10-year Follow-On). ObservationProcedures: Vienna Fluid Monitor or Notal OCT Analyzer applied to macular cube scans. OutcomeMeasures: Intraretinal fluid (IRF), subretinal fluid (SRF), and pigment epithelial detachment (PED) volumes. RESULTS: The fluid volumes measured in neovascular AMD were expressed efficiently in nanoliters. Large ranges that differed by population were observed at the treatment-naïve stage: 0-3,435 nL (IRF), 0-5,018 nL (SRF), and 0-10,022 nL (PED). Mean volumes decreased rapidly and consistently with anti-vascular endothelial growth factor therapy. During maintenance therapy, mean IRF volumes were highest in Tel-Aviv (100 nL), lower in Belfast and HARBOR-Pro Re Nata, and lowest in HARBOR-monthly (21 nL). Mean SRF volumes were low in all: 30 nL (HARBOR-monthly) and 48-49 nL (others). CONCLUSIONS: Quantitative measures of IRF, SRF, and PED are important biomarkers in NV-AMD. Accurate volumes can be extracted efficiently from OCT scans by artificial intelligence algorithms to guide the treatment of exudative macular diseases. Automated fluid monitoring identifies fluid characteristics in different NV-AMD populations at baseline and during follow-up. For consistency between studies, we propose the nanoliter as a convenient unit. We explore the advantages of using these quantitative metrics in clinical practice and research. Published by Elsevier Inc.
PURPOSE: To evaluate retinal fluid volume data extracted from optical coherence tomography (OCT) scans by artificial intelligence algorithms in the treatment of neovascular age-related macular degeneration (NV-AMD). DESIGN: Perspective. METHODS: A review was performed of retinal image repository datasets from diverse clinical settings. SETTINGS: Clinical trial (HARBOR) and trial follow-on (Age-Related Eye Disease Study 2 10-year Follow-On); real-world (Belfast and Tel-Aviv tertiary centers). PATIENTS: 24,362 scans of 1,095 eyes (HARBOR); 4,673 of 880 (Belfast); 1,470 of 132 (Tel-Aviv); 511 of 511 (Age-Related Eye Disease Study 2 10-year Follow-On). ObservationProcedures: Vienna Fluid Monitor or Notal OCT Analyzer applied to macular cube scans. OutcomeMeasures: Intraretinal fluid (IRF), subretinal fluid (SRF), and pigment epithelial detachment (PED) volumes. RESULTS: The fluid volumes measured in neovascular AMD were expressed efficiently in nanoliters. Large ranges that differed by population were observed at the treatment-naïve stage: 0-3,435 nL (IRF), 0-5,018 nL (SRF), and 0-10,022 nL (PED). Mean volumes decreased rapidly and consistently with anti-vascular endothelial growth factor therapy. During maintenance therapy, mean IRF volumes were highest in Tel-Aviv (100 nL), lower in Belfast and HARBOR-Pro Re Nata, and lowest in HARBOR-monthly (21 nL). Mean SRF volumes were low in all: 30 nL (HARBOR-monthly) and 48-49 nL (others). CONCLUSIONS: Quantitative measures of IRF, SRF, and PED are important biomarkers in NV-AMD. Accurate volumes can be extracted efficiently from OCT scans by artificial intelligence algorithms to guide the treatment of exudative macular diseases. Automated fluid monitoring identifies fluid characteristics in different NV-AMD populations at baseline and during follow-up. For consistency between studies, we propose the nanoliter as a convenient unit. We explore the advantages of using these quantitative metrics in clinical practice and research. Published by Elsevier Inc.
Authors: Robyn H Guymer; Caroline M Markey; Ian L McAllister; Mark C Gillies; Alex P Hunyor; Jennifer J Arnold Journal: Ophthalmology Date: 2018-11-29 Impact factor: 12.079
Authors: Stephanie J Chiu; Michael J Allingham; Priyatham S Mettu; Scott W Cousins; Joseph A Izatt; Sina Farsiu Journal: Biomed Opt Express Date: 2015-03-09 Impact factor: 3.732
Authors: Ursula Schmidt-Erfurth; Hrvoje Bogunovic; Christoph Grechenig; Patricia Bui; Maria Fabianska; Sebastian Waldstein; Gregor S Reiter Journal: Am J Ophthalmol Date: 2020-04-08 Impact factor: 5.258
Authors: Scott M Friedman; Talat H Almukhtar; Carl W Baker; Adam R Glassman; Michael J Elman; Neil M Bressler; Manvi P Maker; Lee M Jampol; Michele Melia Journal: Retina Date: 2015-05 Impact factor: 4.256
Authors: Emily Y Chew; Traci Clemons; John Paul SanGiovanni; Ronald Danis; Amitha Domalpally; Wendy McBee; Robert Sperduto; Frederick L Ferris Journal: Ophthalmology Date: 2012-07-26 Impact factor: 12.079
Authors: Neil M Bressler; Isoken Odia; Maureen Maguire; Adam R Glassman; Lee M Jampol; Mathew W MacCumber; Chirag Shah; Daniel Rosberger; Jennifer K Sun Journal: JAMA Ophthalmol Date: 2019-09-01 Impact factor: 7.389
Authors: Leonard M Coulibaly; Stefan Sacu; Philipp Fuchs; Hrvoje Bogunovic; Georg Faustmann; Christian Unterrainer; Gregor S Reiter; Ursula Schmidt-Erfurth Journal: Eye (Lond) Date: 2022-07-05 Impact factor: 4.456
Authors: Antonio Yaghy; Aaron Y Lee; Pearse A Keane; Tiarnan D L Keenan; Luisa S M Mendonca; Cecilia S Lee; Anne Marie Cairns; Joseph Carroll; Hao Chen; Julie Clark; Catherine A Cukras; Luis de Sisternes; Amitha Domalpally; Mary K Durbin; Kerry E Goetz; Felix Grassmann; Jonathan L Haines; Naoto Honda; Zhihong Jewel Hu; Christopher Mody; Luz D Orozco; Cynthia Owsley; Stephen Poor; Charles Reisman; Ramiro Ribeiro; Srinivas R Sadda; Sobha Sivaprasad; Giovanni Staurenghi; Daniel Sw Ting; Santa J Tumminia; Luca Zalunardo; Nadia K Waheed Journal: Exp Eye Res Date: 2022-05-04 Impact factor: 3.770
Authors: Maximilian Pfau; Soumya Sahu; Rawan Allozi Rupnow; Kathleen Romond; Desiree Millet; Frank G Holz; Steffen Schmitz-Valckenberg; Monika Fleckenstein; Jennifer I Lim; Luis de Sisternes; Theodore Leng; Daniel L Rubin; Joelle A Hallak Journal: Transl Vis Sci Technol Date: 2021-06-01 Impact factor: 3.283
Authors: Beau J Fenner; Chui Ming Gemmy Cheung; Shaun S Sim; Won Ki Lee; Giovanni Staurenghi; Timothy Y Y Lai; Paisan Ruamviboonsuk; Gregg Kokame; Yasuo Yanagi; Kelvin Y C Teo Journal: Eye (Lond) Date: 2021-07-14 Impact factor: 3.775